UTI Fiscal Q3 2026 Earnings: Enrollment Growth Comes With Lower Profit
Universal Technical Institute (NYSE: UTI) reported fiscal Q3 2026 revenue of $218.9 million, up 7.2% year over year, while diluted EPS fell to $0.04 from $0.19 for the quarter ended June 30, 2026. Average active students increased 5.8% and new student starts rose 10.9%, but operating expenses grew faster than revenue as the company invested in new campuses and program expansions. UTI also reduced its fiscal 2026 financial guidance, primarily citing fourth-quarter enrollment timing and, to a lesser degree, program mix.
Core earnings data
Revenue increased by $14.6 million, but operating expenses rose by $25.5 million, causing operating income and net income to decline. Management attributed the earnings pressure primarily to strategic growth spending, including $9.0 million that affected adjusted EBITDA during the quarter.
| Metric | Fiscal Q3 2026 | Fiscal Q3 2025 | Year-over-year change |
|---|---|---|---|
| Revenue | $218.9 million | $204.3 million | +7.2% |
| Operating expenses | $215.7 million | $190.1 million | +13.4% |
| Operating income | $3.2 million | $14.2 million | -77.1% |
| Operating margin | Approximately 1.5% | Approximately 6.9% | -5.4 percentage points |
| Net income | $2.3 million | $10.7 million | -78.6% |
| Diluted EPS | $0.04 | $0.19 | -78.9% |
| Adjusted EBITDA | $18.2 million | $25.3 million | -27.8% |
Adjusted EBITDA is a non-GAAP measure that excludes items including interest, taxes, depreciation and amortization, stock-based compensation, integration costs, and restructuring costs.
Business and segment performance
The two operating segments showed different enrollment patterns. UTI drove the increase in new student starts, while Concorde generated faster revenue growth and higher average active enrollment despite a slight decline in new starts.
| Segment | Q3 revenue | Revenue change | New student starts | Start change |
|---|---|---|---|---|
| UTI | $138.0 million | +5.0% | 3,491 | +23.4% |
| Concorde | $80.9 million | +11.1% | 2,851 | -1.4% |
UTI’s average full-time active students increased 4.0% to 14,767, while Concorde’s increased 8.5% to 10,364. Segment earnings moved in opposite directions: UTI net income fell to $5.0 million from $16.4 million, whereas Concorde net income increased to $3.1 million from $1.1 million.
Segment comparisons reflect UTI’s revised corporate cost-allocation methodology, which took effect on October 1, 2025. Prior-year segment figures were recast for comparability.
Following the quarter’s end, UTI-Atlanta opened in July with initial student starts approximately 30% above the company’s expectations. Management also said UTI-San Antonio was tracking ahead of its launch model, supporting demand for the skilled-trades portfolio.
Growth investments are pressuring both earnings and cash flow
UTI’s enrollment growth has not yet translated into higher consolidated earnings because expenses associated with additional students, campus launches, and program expansions are being incurred ahead of their expected benefits. Compensation and benefits increased to $114.9 million from $102.8 million, advertising rose to $26.1 million from $22.7 million, and depreciation and amortization increased to $10.4 million from $8.3 million.
The same investment cycle affected cash generation. The cash-flow figures below cover the nine months ended June 30, 2026, rather than the fiscal third quarter alone.
| Metric | Current value | Comparison or context |
|---|---|---|
| Nine-month operating cash flow | $17.4 million | $40.2 million a year earlier |
| Nine-month cash capital expenditures | $85.4 million | Primarily campuses, programs, equipment, facilities, and IT |
| Nine-month adjusted free cash flow | -$65.6 million | $15.0 million a year earlier |
| Cash and cash equivalents | $130.1 million | $127.4 million at September 30, 2025 |
| Short-term investments | $40.1 million | $41.8 million at September 30, 2025 |
| Available liquidity | $180.5 million | Includes revolving-credit capacity |
| Total debt | $160.0 million | Includes $95.0 million drawn on the revolver |
Higher capital spending was the largest direct factor behind negative adjusted free cash flow. Total debt also increased from approximately $87.1 million at the end of fiscal 2025 to $160.0 million, indicating that the expansion program is relying partly on additional borrowing even as cash balances remain relatively stable.
Fiscal 2026 guidance
UTI lowered its fiscal 2026 revenue, earnings, adjusted EBITDA, and adjusted free cash flow ranges while narrowing its outlook for new student starts. Management said the changes largely reflect enrollment timing and, to a lesser extent, mix rather than a deterioration in underlying student or employer demand.
| Metric | Updated FY2026 guidance | Previous guidance | Change |
|---|---|---|---|
| New student starts | 31,900–32,300 | 31,500–33,000 | Range narrowed |
| Revenue | $893–$900 million | $905–$915 million | Lowered |
| Net income | $32–$36 million | $40–$45 million | Lowered |
| Diluted EPS | $0.57–$0.64 | $0.71–$0.80 | Lowered |
| Adjusted EBITDA | $100–$103 million | $114–$119 million | Lowered |
| Adjusted free cash flow | -$20 million to $0 | $20–$25 million | Lowered |
The company’s adjusted free cash flow outlook assumes approximately $110 million of fiscal 2026 cash capital expenditures. Management separately said baseline adjusted EBITDA should exceed $135 million, compared with reported adjusted EBITDA guidance of $100 million to $103 million after approximately $35 million of growth investments.
Management’s view
Management said demand is shifting toward skilled-trades programs faster than anticipated, helping newer campuses, capacity expansions, and recently launched programs outperform internal models. The main near-term enrollment issue is in fourth-quarter high-school starts for Auto and Diesel programs, which are tracking below plan because UTI did not reach every prospective student who had expressed interest.
The company has also placed its programs under a unified corporate structure and begun a multi-year transition toward a simplified operating model. The objective is to standardize processes, streamline operations, and align resources with demand, although the company did not provide quantified savings from this initiative.
Recent insider transactions
The supplied insider dataset shows 105,001 shares of reported purchases across 11 transactions and 3,337,160 shares of sales across 13 transactions during the past six months, resulting in net sales of 3,232,159 shares. These figures should be viewed as transaction records rather than evidence of insiders’ expectations, particularly because the individual records also include stock awards and gifts.
The latest 10 reported transactions were predominantly sales, including a $124.2 million transaction by Coliseum Capital Management.
| Insider | Role | Transaction | Reported value | Date |
|---|---|---|---|---|
| Jerome Alan Grant | CEO | Sale at $41.15–$41.63 per share | $3,912,306 | Jun. 29, 2026 |
| Kevin Prehn | Officer | Sale at $40.00 per share | $181,800 | Jun. 22, 2026 |
| Coliseum Capital Management, L.L.C. | Insider entity | Sale at $41.40 per share | $124,200,000 | Jun. 8, 2026 |
| Christine Kline | Officer | Sale at $44.42 per share | $155,476 | Jun. 5, 2026 |
| William J. Lennox Jr. | Director | Stock gift at $0 | $0 | Jun. 5, 2026 |
| Tracy Kay Lorenz | Officer | Stock award at $0 | $0 | May 22, 2026 |
| Linda J. Srere | Director | Sale at $36.59 per share | $548,800 | May 11, 2026 |
| Christopher E. Kevane | Officer | Sale at $37.55 per share | $888,115 | Mar. 27, 2026 |
| George W. Brochick | Director | Sale at $36.59 per share | $182,938 | Mar. 17, 2026 |
| Shannon Lei Okinaka | Director | Sale at $34.74 per share | $347,414 | Mar. 6, 2026 |
Risks investors need to watch
- Growth spending may continue to outpace revenue gains. Operating expenses increased 13.4% against 7.2% revenue growth, and the company expects approximately $35 million of fiscal 2026 growth investments.
- Fourth-quarter enrollment conversion is below plan in some programs. Weaker-than-planned high-school starts in Auto and Diesel contributed to the lower full-year outlook, even though overall student interest remains healthy according to management.
- Capital intensity is weighing on liquidity and leverage. Nine-month adjusted free cash flow was negative $65.6 million, and debt increased as UTI funded campus and program expansion.
- Segment enrollment trends are uneven. UTI new starts increased 23.4%, but Concorde starts declined 1.4%, creating a potential pipeline issue if the decline persists despite current growth in active students.
- The operating-model transition adds execution risk. UTI is beginning a multi-year restructuring and standardization effort while continuing to open campuses and add programs, increasing the number of initiatives management must execute simultaneously.
Summary
UTI’s fiscal third quarter showed that student demand and revenue are still expanding, led by a sharp increase in new starts at the UTI segment and encouraging early demand at newer campuses. However, campus launches, program expansion, and other strategic investments drove expenses above revenue growth, reduced earnings, and contributed to negative year-to-date free cash flow. The next points to monitor are fourth-quarter enrollment conversion, returns from newer campuses, execution of the unified operating model, and whether fiscal 2027 growth begins to absorb the current investment burden.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles









Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.